Long-term health check for premature babies who had antibiotics
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study follows up on babies who took part in the NANO study, which looked at how antibiotics given in the NICU affect health. Researchers will check on these children over time to see how they are doing in the long run.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was enrolled in the original NANO study.
- Babies were born very early, between 23 and 30 weeks of pregnancy.
- Babies were born at a hospital that is part of the study.
- At the start, babies did not have signs of infection or high risk for infection, and did not need very high oxygen support.
- Babies did not have major birth defects or a life expectancy of less than 3 days.
- Babies had not received antibiotics before being assigned to a study group.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving probiotics (good bacteria) to preterm infants who received antibiotics can help their brain development. Your baby will get either a probiotic supplement or a placebo for 6 months, and we'll check their development.
This trial tests whether a combination of two antibiotics (azithromycin and ampicillin) can help pregnant people whose water has broken between 34 and 36 weeks of pregnancy. The goal is to see if this treatment improves outcomes for both the parent and baby without causing early labor or infection.
This study looks at how involving family members in the care of premature babies in the neonatal intensive care unit (NICU) might improve the baby's quality of life. If your baby was born early and spent time in the NICU, this study could help us understand how family involvement affects outcomes.
This study tests a new antibiotic called aztreonam-avibactam (ATM-AVI) for treating serious bacterial infections in hospitalized babies under 9 months old. The goal is to see if it's safe and works well.
This study gives preterm babies the standard antibiotic ampicillin and checks the amount in their blood to find the best dose. It may help make sure the medicine works well and is safe for babies born early.
This trial compares giving antibiotics to all preterm babies at risk of infection versus giving them only if symptoms develop. It aims to find out if waiting is safer and reduces unnecessary antibiotic use.
Hear when a new Premature Birth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.